60556-50-5Relevant articles and documents
COMBINATION TREATMENT OF BACTERIAL INFECTION
-
Paragraph 0117; 0118, (2020/06/08)
The present invention resides in the discovery that combined use of kuraridin (or any one of its analogs) and epicatechin gallate (ECG) can provide heightened level of antimicrobial activity, especially for the suppression of bacteria of the Staphylococcus aureus and Staphylococcal species. Compositions, kits, and methods for the combination use are disclosed.